Table 5.
Propensity score-adjusted competing-risks regression analysis measuring the association between individual compliance measures and survival.
| Variable | HR | 95% CI |
|---|---|---|
| Cystoscopy
| ||
| <4 Cystoscopies (referent) | 1.00 | … |
| ≥4 Cystoscopies | 0.61 | (0.47–0.79) |
|
| ||
| Cytology
| ||
| <4 Cytologies (referent) | 1.00 | … |
| ≥4 Cytologies | 0.55 | (0.39–0.80) |
|
| ||
| Upper Tract Imaging
| ||
| No upper tract image (referent) | 1.00 | … |
| ≥1 Upper tract image | 1.15 | (0.77–1.73) |
|
| ||
| Perioperative Instillation of Mitomycin C
| ||
| No instillation of mitomycin C after any TURBT (referent) | 1.00 | … |
| At least one instillation of mitomycin C after any TURBT | 0.74 | (0.34–1.65) |
|
| ||
| Postoperative Instillation of BCG
| ||
| No instillations, or ≥ 1 instillation with 1st dose after 90 days (referent) | 1.00 | … |
| ≥1 instillation with 1st dose within 90 days | 0.71 | (0.51–0.98) |